Troluce Capital Advisors’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-32,297	Closed	-$872K	–	27
2025 Q1	$872K	Hold	32,297	–	–	0.26%	12
2024 Q4	$1.73M	Buy	+32,297	New	+$1.73M	0.06%	12